8.30am-9.00am Registration & Exhibition Open, Welcome Tea & Coffee
9.00am-10.00am NZACRes AGM
10.00am-10.05am WELCOME BACK ~ Meghan McIlwain, President, NZACRes
10.05am-10.30am Māori involvement in Clinical Cancer Genomics Research Chair: Meghan McIlwain
Dr Kimiora Henare, Cancer Biologist, The University of Auckland, NZ
10.30am-11.00am Morning Tea and Industry Exhibition
9.00am-10.00am NZACRes AGM
10.00am-10.05am WELCOME BACK ~ Meghan McIlwain, President, NZACRes
10.05am-10.30am Māori involvement in Clinical Cancer Genomics Research Chair: Meghan McIlwain
Dr Kimiora Henare, Cancer Biologist, The University of Auckland, NZ
10.30am-11.00am Morning Tea and Industry Exhibition
|
Chair: Brendan Swan
11.00am-12.00pm Panel Discussion - The Rakeiora Project Professor Cristin Print, Molecular Medicine and Pathology, The University of Auckland Dr Kimiora Henare, Cancer Biologist, University of Auckland, NZ Dr Claire Rye, Product Manager, New Zealand eScience Infrastructure, Auckland, NZ Dr Helen Wihongi, National General Manager Māori Research, Te Whatu Ora & Te Aka Whai Ora, NZ Vertical Divider
|
Chair: Meghan McIlwain
11.00am-12.00pm Panel Discussion: Alternatives to an Academic Career Dr Lakshini Mendis-David, Freelance Medical Writer, MedComm Matters, Australia Dr Greg O'Grady, Professor of Surgery, University of Auckland, NZ |
12.00pm-1.00pm Lunch and Industry Exhibition
|
Concurrent 1 - Advances in Australia Chair: Charlie Stratton
1.00pm-1.25pm Advances in Australia: Some Thoughts from a New Zealander Working in Both Countries Scott Bannan, Clinical Research Director, MSD 1.25pm-1.50pm Workforce Development and the Research Competency Framework Robert Kent, Research Operations Manager, The Kinghorn Cancer Centre, Australia 1.50pm-2.15pm Advances in Australia Karen West, General Manager Australia & New Zealand, Syneos Health 2.15pm-2.45pm Panel Discussion Scott Bannan, Clinical Research Director, MSD Karen West, General Manager Australia & New Zealand, Syneos Health Robert Kent, Research Operations Manager, The Kinghorn Cancer Centre, Australia Vertical Divider
|
Concurrent 2 - Biotechnology and Devices Chair: Julie Jones
1.00pm-1.25pm The NZ Biotechnology Sector Dr Zahra Champion, Director, BIOTech New Zealand 1.25pm-1.50pm Te Titoki Mataora MedTech Research Translator : A Considered Strategy in Research Translation Dr Diana Siew, Strategic Partnerships Lead, Auckland Bioengineering Institute, University of Auckland 1.50pm-2.15pm Use of GMOs in Therapeutic Products - The EPA Perspective Dr Milan Gagic, Senior Advisor, New Organisms, Environmental Protection Authority - Te Mana Rauhī Taiao 2.15pm-2.45pm Panel Discussion Dr Zahra Champion, Director, BIOTech New Zealand Dr Diana Siew, Strategic Partnerships Lead, Auckland Bioengineering Institute, University of Auckland Dr Milan Gagic, Senior Advisor, New Organisms, Environmental Protection Authority - Te Mana Rauhī Taiao |
2.45pm-3.15pm Afternoon Tea and Industry Exhibition
|
Chair: Christopher Taylor
3.15pm-3.45pm Mental Health Clinical Research Professor Bruce Russell, Associate Dean, Clinical Pharmacy, University of Otago 3.45pm-4.15pm KLKB1 Gene Editing Treatment for Patients with Hereditary Angioedema ...including patient perspective and journey Dr Hilary Longhurst, Senior Medical Office (Immunology) Auckland Hospital, Honorary Associate Professor University of Auckland Vertical Divider
|
3:15pm - 3:45pm Chair: Katie Rice Borroz
Post-Graduate Student “Lightning Round” Presentations ICare-SALLEE: Investigating Care Processes, through Standardised Allocation to Emergent Exercise Stress Testing Eleanor Dunn, Student, University of Otago, School of Medicine Caffeine Prophylaxis to Improve Intermittent Hypoxaemia in Late Preterm Infants: The Latte Dosage Trial Elizabeth Oliphant, Department of Paediatrics: Child & Youth Health and School of Pharmacy, University of Auckland The Effect of Prebiotic Food on Sleep Patterns during Complementary Feeding in First-Year Infants Xiaoxi Fu, PhD Candidate, University of Auckland Investigating Magnetic Resonance Imaging Correlates of Anti-Inflammatory Treatment in Major Depressive Disorder Benjamin Moloney, University of Auckland, School of Pharmacy 3:50pm - 4:10pm
Clinician Investigator “Lightning Round” Presentations Do Glycaemic Treatment Targets Affect the Perinatal Mental Health Status of Women with Gestational Diabetes? – Data from the TARGET Trial Dr Phyllis Ohene-agyei, PhD Student, Liggins Institute The FIIX Study: A Non-Inferiority Randomised Controlled Trial comparing Intrauterine Insemination with Ovarian Stimulation (IUI-OS) with In Vitro Fertilisation (IVF) in Couples with Unexplained Infertility Dr Lucy Prentice, Doctoral Student, Department of Obstetrics and Gynaecology, University of Auckland |
4.15pm-4.45pm Anti-CD19 CAR T-Cell Therapy Clinical Research in New Zealand Chair: Christopher Taylor
Dr Philip George, Co-Investigator, ENABLE Trial
Dr Philip George, Co-Investigator, ENABLE Trial
4.45pm-5.15pm Reflections of a Genetically Modified Optimist
David Downs, Genetically Modified Optimist & CEO, NZ Story
David Downs, Genetically Modified Optimist & CEO, NZ Story
5.15pm-5.30pm Awards & Conference Close
Meghan Mcilwain, President NZACRes
Prizes donated by BeiGene will be awarded by Erica Currie, BeiGene NZ Unlimited
Meghan Mcilwain, President NZACRes
Prizes donated by BeiGene will be awarded by Erica Currie, BeiGene NZ Unlimited
